Featured
Patients pick favourite pharma
One company shot up the rankings by four places to be declared the top Big Pharma when it comes to corporate reputation, judged by diabetes patients
Government & Policy
Biologics finally move to first line in paediatric Crohn's
Acting PBAC Chair tells Senate Estimates that "sponsors are just not commercially enticed" to paediatric populations
Industry & Companies
MA lands its 50th member
A new member of Medicines Australia has seen the ranks of the industry organisation swell to 50
Pipeline & Intellectual Property
CEO stands by takeover despite US$1.9B hit
Insists the phase 3 fail of one of the deal's key assets is just a “bump” for the company and the price of pioneering science
Featured
Ex-Aussie GM lands top new role
Less than three years after leaving Australia, this leader who spent five years heading the ANZ team has won another promotion
Industry & Companies
Aussie repurposer swaps shares for NZ start-up
The move gives access to a repurposed treatment for patients with multiple sclerosis, with the buy raising capital to fund the drug's trial
Regulatory & Reimbursement
Action urged on 'dangerously under-recognised' disease
Boehringer has launched a report to increase public awareness and exhort government action on a disease that makes people feel their lungs are concrete
Industry & Companies
Top pharma employers as voted by staff
Twelve pharmas made the Top 20 science-focused companies to work for list, voted in by the people who work there. See who made the cut
Government & Policy
Dept boasts faster medicines access
Annual Report hails 100 per cent strike rate on six-months-to-listing target but the fine print reveals the numbers don't tell the full story
Industry & Companies
Is pharma finally in a good mood?
The bright future pharma has been dreaming of has arrived... at least for some with positive sentiment on a steep climb - except when it comes to the prospect of finding a new job
Pipeline & Intellectual Property
Cancer drug's 'unprecedented' trial results
Slashes the risk of death by 58% in this lung cancer patient cohort, with the company describing the findings as a watershed moment in the management of the disease
Featured
Ex-BMS exec wins Aussie Country Lead role
After more than 15 years at BMS, this well-known executive has joined a Canadian company to lead its Australian operations
Industry & Companies
CSL grilled by many cooks
Shareholders turned up the heat at the company's AGM this morning, with the outgoing Chair conceding it had overpaid for an US$11.7B acquisition
Regulatory & Reimbursement
Four pharmas start run for Govt funding
A company navigating Australia's reimbursement system for the first time is kicking off the race for Government funding
Leadership & People
Pharma exec shares life lessons after horror bus crash
National Sales Manager Sharyn Junkeer shares the lessons she's painfully learned about life and career after suffering critical injuries in a horror bus crash
Featured
Company announces another leadership change
Long-time boss to be replaced next year by someone whose history with the organisation runs just as deep
Government & Policy
Butler talks security in the wake of Haines attack
Health Minister has not upped his security in the last week, but concedes changes likely need to be made
Industry & Companies
Astellas turns up the heat on politicians
Temperatures were high when three Sydney MPs visited the pharma's Macquarie Park office. Find out why
Regulatory & Reimbursement
PBAC-ticked gene therapy wins TGA nod
A new form of a gene therapy expands the indicated population to catch those who weren't diagnosed in time
Popular
Farewells dominate Aussie pharma job moves
Departures from companies, Australia and even industry have dominated the latest round of job moves across pharma
Jobs
Pipeline & Intellectual Property
Secret data leak, landmark results... then a share tumble
Over a tumultuous few hours, impressive data on the world's first mRNA cancer vaccine was leaked, then praised, before a tumble on the stock market
Awards
LinkedIn names Australia's best workplaces
Healthtech has emerged as a major force in this year’s LinkedIn Top Startups Australia list, an annual ranking of the emerging companies where professionals want to work
Pipeline & Intellectual Property
Aussies tapped for US gene project
UQ researchers selected to help the US produce personalised genetic therapies in hospitals to deliver RNA medicines to patients within days of diagnosis, instead of months
Government & Policy
Australia's long road to closing CAR T gap
Funding CAR T treatments isn't enough when structural barriers prevent the majority of referrals from accessing CAR T.
Leadership & People
Pharma boss smashes two glass ceilings
Inducted into the Hall of Fame as a "pioneer of breaking glass ceilings" in both gender and age, this pharma leader has been honoured for her vision and courage
Leadership & People
Ex-Aussie GM nabs top job with newcomer
This well-known boss is back in Australia and leading the region for a company that's chasing approvals globally for a drug that's been hailed a game-changer
Industry & Companies
Arrotex signs deal for locally-developed med
Agreement brings together innovative anti-infective development platform and the Aussie giant's established regulatory, market access and commercial capabilities
Jobs & Workplace
Feeling disengaged? Here's what might be missing
An industry survey has uncovered the most important motivator for workplace engagement with more than 2300 open-ended comments pointing to one must-have
Regulation & Legal
CSL slapped with investor class action
A lawsuit has been filed by investors who bought shares during a calamitous price plunge but CSL has promised to 'vigorously' defend all accusations
Latest
BioNTech opens Aussie mRNA facility
World-class facility in Melbourne will help deliver the next generation of life-changing treatments in cancer, heart disease, and neurological and autoinflammatory diseases
- Leadership & People CSL names ex-Aussie GM as new CEO
- Patients Aussie patient groups speak up on pricing
- Industry & Companies Aussie industry mega-event in full swing
- Industry & Companies Can doctors be bought for the price of a sandwich?
- Industry & Companies Time-poor doctors move from papers to podcast
- Regulatory & Reimbursement 15 drugs jostle for November PBS listings
- Industry & Companies Takeover sends shares tumbling by 34%
- Industry & Companies Bots move in at pharma logistics base
- Government & Policy Trump splurges on Big Pharma shares
- Regulatory & Reimbursement PBAC tweaks November Agenda